A Safety and Efficacy Study of OZURDEX in Macular Edema Associated With Branch Retinal Vein Occlusion (COBALT)

Trial Profile

A Safety and Efficacy Study of OZURDEX in Macular Edema Associated With Branch Retinal Vein Occlusion (COBALT)

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jul 2016

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Branch retinal vein occlusion; Retinal oedema
  • Focus Therapeutic Use
  • Acronyms COBALT
  • Sponsors Allergan
  • Most Recent Events

    • 26 Apr 2016 Data will be presented at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), as per Allergan media release.
    • 22 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 22 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top